Literature DB >> 15527699

Clinical trials in Kawasaki disease.

Thomas J A Lehman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15527699     DOI: 10.1007/s11926-004-0019-y

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  5 in total

1.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

2.  Altered myocardial flow reserve and endothelial function late after Kawasaki disease.

Authors:  Hideto Furuyama; Yasuhisa Odagawa; Chietsugu Katoh; Yasuyoshi Iwado; Yoshinori Ito; Kazuyuki Noriyasu; Megumi Mabuchi; Keiichirou Yoshinaga; Yuji Kuge; Kunihiko Kobayashi; Nagara Tamaki
Journal:  J Pediatr       Date:  2003-02       Impact factor: 4.406

3.  Kawasaki disease: effect of treatment on coronary artery involvement.

Authors:  H Kato; S Koike; T Yokoyama
Journal:  Pediatrics       Date:  1979-02       Impact factor: 7.124

4.  Can we prevent long term cardiac damage in Kawasaki disease? Lessons from Lactobacillus casei cell wall-induced arteritis in mice.

Authors:  T J Lehman
Journal:  Clin Exp Rheumatol       Date:  1993 May-Jun       Impact factor: 4.473

5.  Successful catheter interventional therapy for acute coronary syndrome secondary to kawasaki disease in young adults.

Authors:  Nobuyuki Negoro; Jin Nariyama; Atsushi Nakagawa; Hiroshi Katayama; Taichi Okabe; Hiroshi Hazui; Naohito Yokota; Shigeyuki Kojima; Masaaki Hoshiga; Hiroshi Morita; Tadashi Ishihara; Toshiaki Hanafusa
Journal:  Circ J       Date:  2003-04       Impact factor: 2.993

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.